4
Changes in Ownership
Pharvaris N.V. Filed Acc 0001193125-26-206273
Chief Medical Officer sold 14,166 shares at an average $30.17 ($427,419)
- Chief Medical Officer acquired 14,166 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lu Peng · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,166 | $2.59 | $36,690 | 80,249 | D |
| 2026-05-01 | Sale : show line 2 in the form 10b5-1 | −14,023 | $30.16 | $422,986 | 66,226 | D |
| 2026-05-01 | Sale : show line 3 in the form 10b5-1 | −143 | $31.00 | $4,433 | 66,083 | D |
| Open-market sales · 14,166 sh · avg $30.17 · $427,419 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-01 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −14,023 | 205,451 | D |
| 2026-05-01 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −143 | 205,308 | D |
Loading xslF345X06/ownership.xml…